Free Trial
→ Why Iran May Only Be the First Move (From Behind the Markets) (Ad)tc pixel
NASDAQ:PRE

Prenetics Global Q3 2026 Earnings Date & Estimates

Prenetics Global logo
$17.35 -0.20 (-1.12%)
As of 02:17 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Prenetics Global is estimated to report Q3 2026 earnings on Wednesday, November 18, 2026, before market opens. The conference call is scheduled for 8:30 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
8:30 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Prenetics Global in Q3 2026

Prenetics Global is expected to post earnings of -$0.82 per share on revenue of $63.28 million. In the same quarter a year earlier Prenetics Global reported -$0.41 per share on revenue of $23.56 million. Prenetics Global last reported on August 19, 2026, posting -$0.53 per share and beating the -$0.84 consensus estimate. Prenetics Global has beaten the consensus EPS estimate in 4 of its last 5 quarters.

Consensus Estimates

Consensus EPS
-$0.82
Expected Revenue
$63.28 million
Prior-Year EPS
-$0.41
Prior-Year Revenue
$23.56 million
Expected Revenue Growth
+168.6%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.53 (Beat by +$0.31)
Last Quarter Revenue
$46.49 million
EPS Beat Rate
4 of last 5 quarters

Prepare for the Q3 2026 Call

Prenetics Global Q3 2026 Earnings FAQ

Prenetics Global (NASDAQ:PRE) is estimated to report Q3 2026 earnings on Wednesday, November 18, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Prenetics Global's Q3 2026 earnings conference call is scheduled for Wednesday, November 18, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Prenetics Global to post earnings of -$0.82 per share for Q3 2026.

The consensus revenue estimate for Prenetics Global is $63.28 million for Q3 2026.

Prenetics Global Earnings Headlines

PRE Announces Strategic Partnership
November 5, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/pre-announces-strategic-partnership-110000386.html
Prenetics’ IM8 and Authentic Brands Group Announce 10-Year Exclusive Global Partnership to Create Care Bears by IM8; Authentic to Become Strategic Shareholder in Prenetics
November 5, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/prenetics-im8-authentic-brands-group-133000775.html
Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.tc pixel
November 10 at 1:00 AM  |  Behind the Markets (Ad)
Care Bears And Prenetics' IM8 Announce Global Partnership
November 5, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/care-bears-and-prenetics-im8-announce-global-partnership-302930786.html
Prenetics' IM8 and Authentic Brands Group Announce 10-Year Exclusive Global Partnership to Create Care Bears by IM8; Authentic to Become Strategic Shareholder in Prenetics
November 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/11/05/3396443/0/en/prenetics-im8-and-authentic-brands-group-announce-10-year-exclusive-global-partnership-to-create-care-bears-by-im8-authentic-to-become-strategic-shareholder-in-prenetics.html
Prenetics Global Names Brian Rosin to Succeed Stephen Lo as CFO
November 3, 2026  |  marketscreener.comM
See More Prenetics Global Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Prenetics Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Prenetics Global and other key companies, straight to your email.

About Prenetics Global

Prenetics Global (NASDAQ:PRE) is a health sciences and genomics company founded in 2014 by Danny Yeung, who serves as its chief executive officer. Headquartered in Hong Kong, the company uses genetic sequencing, molecular diagnostics and data analysis to support consumer health, clinical care and early disease detection.

Its consumer business operates under the CircleDNA brand, which offers at-home DNA testing and reports covering areas such as wellness, nutrition, fitness, traits and genetic risk. Prenetics also provides clinical genomics services, including cancer-related testing and molecular profiling through its ACT Genomics business, which is designed to help physicians better understand tumors and inform treatment decisions.

Prenetics has also invested in early cancer-detection technologies through Insighta, a joint venture focused on blood-based tests intended to identify cancer at earlier stages. The company serves customers and healthcare organizations across markets in Asia and other international regions, including the United States and the United Kingdom, through a combination of direct-to-consumer products, laboratory services and partnerships.

View Prenetics Global Profile
Earnings Tools